The repeatability and agreement of biometric measurements by dual Scheimpflug device with integrated optical biometer.
Hassan Hashemi, Sara Sardari, Abbasali Yekta...
https://pubmed.ncbi.nlm.nih.gov/35546610/Actively Recruiting
Led by Cassini Technologies · Updated on 2026-01-08
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating a new device called the Helioscope, developed by Cassini Technologies B.V., which combines LED-based corneal topography with swept-source optical coherence tomography SS-OCT to quickly and accurately measure the shape of the cornea and other eye structures. This next-generation optical biometer is designed to provide measurements even in eyes with dense cataracts, which can affect optical properties and measurement accuracy. The study aims to collect data from eyes with cataracts to help improve the devices software algorithms. Participants will have their eye measurements taken in a single visit using three devices the investigational Helioscope optical biometer, and two FDA-cleared comparator devicesthe Cassini Ambient corneal topographer and the Argos optical biometer. These measurements will be compared to evaluate the accuracy and agreement of the new device. There is no treatment or intervention assignment as part of this study it focuses solely on diagnostic comparison. During the study visit, participants will undergo ocular biometry to measure parameters such as axial length, keratometry, anterior chamber depth, lens thickness, and total corneal astigmatism using all three devices. Researchers will monitor the measurements over a period of up to 12 months to assess the Helioscopes performance in cataractous eyes. Safety is ensured by selecting participants able to provide informed consent and properly fixate during measurements.
CONDITIONS
Development of Optical Biometer
D
Dr. Michael Petrik Petrik, OD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cassini Technologies
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational Optical Biometer | Current FDA-cleared Biometry Devices |
|---|---|---|
| What is it? | A new diagnostic device designed to measure axial length, keratometry, anterior chamber depth, lens thickness, and corneal astigmatism in adults with cataracts. Its purpose is to provide all key ocular measurements required for planning intraocular lens surgery. | Established FDA-cleared devices (Cassini Ambient for keratometry and Argos for optical biometry) routinely used to obtain the same ocular measurements for preoperative cataract and IOL assessments. |
| Role in this trial | Primary device evaluated for accuracy and agreement in measuring eye parameters in cataract patients. | Served as the clinical reference standard to compare measurement accuracy and agreement with the investigational device. |
| Primary use | Proposed for clinical optical measurements supporting surgical planning for cataracts; its performance is under investigation. | Widely used in clinical practice to guide intraocular lens selection and surgical planning in cataract surgery. |
| How is it performed? | Non-contact imaging and scanning of the eye performed in a clinic to capture all relevant biometric parameters before cataract surgery. | Non-contact or minimal contact exam using FDA-cleared instruments, capturing ocular measurements in standard pre-surgical clinical settings. |
| Regulatory status | Currently investigational; not FDA-cleared or approved for clinical use. | FDA-cleared and approved for clinical use in the United States. |
| Evidence status | Clinical accuracy and agreement are under evaluation in the present trial. Published data on this investigational device is not yet established. | Well-characterized in published literature; comparable devices have shown repeatable, clinically reliable measurement accuracy in cataract patients. |
| Important limitations | Performance, reliability, and agreement with established devices are not yet confirmed; limited data are available until results are posted and peer-reviewed. | Device performance may vary in cases of advanced cataract, media opacity, or unstable fixation. Published studies show moderate variability between different device models. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants undergo ocular biometry measurements using three devices including the investigational optical biometer and two FDA-approved comparator devices during the same visit. These measurements are used for diagnostic comparison only.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Hassan Hashemi, Sara Sardari, Abbasali Yekta...
https://pubmed.ncbi.nlm.nih.gov/35546610/Cassini Technologies
Lead Sponsor